Introduction
Protein-protein interactions are of fundamental importance for transcriptional regulation (reviewed in Lewin, 1990; Ptashne and Gann, 1990) . To determine the relevance of protein-protein interactions for regulatory processes during development, we studied the interaction of two well-known proteins, ElA and Ott-4.
Infection of early mouse embryos with SV40 and polyomavirus demonstrates that early multipotent cell lineages do not support viral replication (reviewed in Kelly and Condamine, 1982) . Until the eight-cell or early morula stage, all cells of the embryo are totipotent, contributing to all cell lineages in any embryonic or extraembryonic tissue. During blastocyst formation cells differentiate into two types, those of the inner cell mass (ICM) and those of the extraembryonictrophectoderm, thefirstfullydifferentiated cell type. When blastocysts are infected with SV40 or polyomavirus, expression of viral genes is detected in trophectodermal cells but not in the ICM. If later embryonic stages are infected, viral genes are also not detected in pluripotent cell populations, e.g., the early embryonic ectoderm until day 9 of gestation. In contrast, differentiated cells are permissive for viral infection (reviewed in Kelly and Condamine, 1982) .
A detailed functional analysis of postinfective viral gene expression in early mouse embryos is made difficult by the limited amount of material. Therefore, embryonal carcinoma (EC) cells have been used as a model system to study viral gene expression in pluripotent stem cells. EC cells resemble early mouse embryonic cells in many respects. They can be maintained in an undifferentiated state, can be induced to differentiate into cells resembling the derivatives of all three germ layers, and can participate in normal embryonic development (Mintz and Illmensee, 1975; Evans and Kaufman, 1981; Martin, 1981) . The lack of expression of SV40 and polyomavirus in early pluripotent cells correlates with the lack of their expression in undifferentiated EC cells (reviewed in Kelly and Condamine, 1982) . This block is due to repression of their enhancers (Borrelli et al., 1984; Gorman et al., 1985; Velcich and Ziff, 1985) . Repression can be overcome by certain mutations in the viral enhancer, allowing expression of the viral genome in undifferentiated EC cells, as describedforthepolyomavirusenhancer(reviewed in Sleigh, 1985) . When the EC cells are induced to differentiate, the block to viral gene expression is relieved. One of these polyoma enhancers that is active in EC cells contains a point mutation and is not repressed by ElA (Hen et al., 1986) , whereas wild-type polyoma enhancer is (Borrelli et al., 1984) . An activity similar to that of ElA seems to be responsible for enhancer repression in undifferentiated EC cells.
An ElA-like activity has originally been postulated to explain the growth of certain adenovirus mutants in EC stem cells (Imperiale et al., 1984) . Deletion of the El A gene prevents the growth of adenoviruses on differentiated cells by blocking the subsequent expression of other adenovirus genes (Berk et al., 1979; Jones and Shenk, 1979) . However, since such viruses grow in EC stem cells, ElA apparently can be replaced by a factor present in these cells, thus named ElA-like factor or ElA-like activity (lmperiale et al., 1984; La Thangue and Rigby, 1987) . Two categories of cellular genes are affected by ElA (Svensson and Akusjarvi, 1984 ; for reviews see Berk, 1986; Flint and Shenk, 1989) . The genes of the 70 kd heat shock protein (Kao and Nevins, 1983) and P-tubulin (Stein and Ziff, 1984) are activated by El A, whereas the genes of the class I antigens of the major histocompatibility complex (MHC) are repressed (Schrier et al., 1983 ). ElA could not be shown to bind to DNA in a sequence-specific manner (Ferguson et al., 1985; Chatterjee et al., 1988) but requires viral or cellular proteins to exert its function. The interaction with DNA might be mediated by such proteins (Ko et al., 1986) . In agreement with this notion, ElA has been shown to interact with multiple cellular proteins (Yee and Branton, 1985; Harlow et al., 1986) .
The well-characterized octamer motif mediates transcriptional activity and is found in various cellular promoters and enhancers, e.g., the immunoglobulin heavy chain (IgH) enhancer (reviewed in Schreiber et al., 1989a) . The IgH enhancer is active in lymphoid cells, whereas it is inactive in fibroblasts. However, in the presence of ectopic El A, the IgH enhancer is repressed in lymphoid cells (Hen et al., 1985) and is activated in fibroblast cells (Borrelli et al., 1986) . Because the octamer sequence of the IgH
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enhancer is the major determinant of its cell type-specific expression (reviewed in Kemler and Schaffner, 1990) proteins interacting with this motif may also interact with ElA and thereby mediate both transcriptional activation and repression, The octamer motif confers transcriptional activity also in undifferentiated F9 ceils (Scholer et al., 1989b) where Ott-4 (also termed Ott-3 or NF-A3) and Ott-6 are expressed but not Ott-2 (Lenardo et al., 1989; Scholer et al., 1989a) . Thus, in F9 cells the octamer is active in the presence of the El A-like activity, and in lymphoid cells the IgH enhancer is repressed by ElA.
In the blastocyst a number of octamer-binding proteins are present and the activity mediated by the octamer is restricted to the ICM (Scholer et al., 1989b) . Thus, the activity pattern of the octamer motif in the blastocyst is reciprocal to the expression pattern of SV40 and poly omavirus. Furthermore, the Ott-4 gene is expressed in pluripotent cells and not in differentiated cells. During the time when the block of viral replication in the embryo is relieved (day 9 of gestation), Ott-4 expression is restricted to the primordial germ cells (Rosner et al., 1990; Schdler et al., 1990b) . Therefore, the expression of Ott-4 and the viral gene expression is reciprocal both in the embryo and in the EC cells. A possible link between both patterns is the EIA-like factor, which might not only repress certain viral enhancers but also stimulate Ott-4-mediated gene expression.
In this report we show that transactivation by Ott-4 is strongly stimulated in the presence of ElA in differentiated cells and that this stimulation can even occur from a downstream enhancer. Stimulation depends on a transactivation domain linked to Ott-4 (Okamoto et al., 1990) , indicating that the activation domain of EiA (Lillie and Green, 1989) or another coactivator (Liu and Green, 1990) cannot substitute for that of Ott-4. In contrast to strong stimulation of Ott-Cmediated gene activation, Ott-2 and Ott-1 only slightly stimulate transcription in the presence of El A. Stimulation by these proteins also depends on their functional transactivation domains. We suggest that distance-independent transcriptional activation reflects thefunctionof ElAasabridgingfactorallowingOctfactors to interact with TATA box factor(s). This notion is supported by cotransfection experiments of ElA and Ott-4 expression vectors into HeLa cells, where a certain ratio of both is necessary for optimal transcriptional activation. Increasing ElA or Ott-4 destroys activation, probably via squelching (Ptashne, 1988) or surface saturation of participating factor(s). Binding of ElA to Ott-4 was demonstrated with proteins translated in vitro. We postulate that ElA can substitute for a bridging factor in pluripotent progenitor cells and that this is the ElA-like factor.
Results
In F9 Cells the Octamer Enhancer 6W Is Repressed by the ElA Product(s) In F9 stem cells and B cells a single octamer motif is active irrespective of its distance from the TATA box. Tandemly arranged octamer motifs function as strong enhancers active in both F9 and B cells (Gerster et al., 1987; Schtjler et al., 1989b) . However, such enhancers are not sufficient to activate transcription in HeLa cells, even when Ott-2, Ott-4, and Ott-6 are ectopically expressed (Miiller-lmmergliick et al., 1988; Schiiler et al., 1990b , Suzuki et al., 1990 . These observations suggest that additional activating proteins are absent or repressing proteins are present in HeLacells, when compared with F9 or Bcells. Transcription is stimulated considerably when the octamer motif and the TATA box are in close proximity, demonstrating that the Ott factors are not intrinsically inactivated in HeLa cells (Miiller-lmmergliick et al., 1988; Rosner et al., 1990; Schdler et al., 1990b; Suzuki et al., 1990) .
The effect of ectopically expressed adenovirus 5 (Ad5) El A on the octamer motif was examined in F9 cells ( Figure  1 ). The target vector used contains six tandem repeats of an IgH fragment in front of a tk minimal promoter, the IgH fragment harboring an octamer motif and a uE4 site (p6WtkCAT; Figure 1 D) . A constant amount of this target vector was cotransfected with varying amounts of an ElA expression vector ( Figure 1E ). Increasing amounts of the ElA expression vector reduced CAT activity ( Figure 1A ) to a level of a vector containing an inactive octamer mutant (p6FdtkCAT). Since the low but measurable level of p6FdtkCAT was not affected by ElA (data not shown), we conclude that the octamer motif mediates repression by ElA.
To determine if ElA affects the binding activity of any Ott protein, aliquots of the transfected F9 cells were examined in the electrophoretic mobility shift assay (EMSA). In contrast to the dramatic decrease in CAT activity, no change is detectable for any of the complexes when ElA is expressed ( Figure 1B) . Therefore, binding of the Ott proteins is not affected.
One possible cause for the decrease in transcriptional activity could be that Ott factors are competed by binding sites in the expression vector. However, this is unlikely, because a 5fold molar excess of the 6W enhancer cloned in Bluescript did not reduce transcriptional activation (data not shown). Therefore, the Ott factors are not limiting in the transactivation experiment outlined above.
The ElA transcription unit encodes several related proteins through the production of alternatively spliced mRNAs (reviewed in Berk, 1986) . The 13s mRNA encodes a protein of 289 amino acids (289R); and the 12s mRNA encodes a protein of 243 amino acids (243R). The larger protein contains a domain of 46 conserved amino acids that is required for transactivation (reviewed in Braithwaite et al., 1991) . To examine if repression is due to any of these proteins, expression vectors containing either 12s or 13s ElA cDNA were cotransfected with the reporter plasmid into F9 cells (Figures 1C and 1E; Weigel et al., 1990) . The expression vector without cDNA sequences was added to the same total amount (Figure 1 E; Gunning et al., 1987) . Large amounts of the 13s expression vector reduced CAT activity to an extent comparable to the whole ElA transcription unit, whereas the same amount of 125 expression vector only slightly reduced the CAT activity. Therefore, the repression of enhancer-mediated activation is mainly due to the 289R ElA protein.
The Octamer Is Not Directly Affected by ElA Protein(s) in F9 Cells Repression of the 6W enhancer activity in F9 ceils resembles repression of the IgH enhancer by ElA in B cells (Hen et al., 1985) . However, the mechanism of repression might be different in both cases. Several publications have outlined an effect of the ElA transcription unit on the differentiation state of F9 cells (Montano and Lane, 1987; Velcich and Ziff, 1989; Nelson et al., 1990; Weigel et al., 1990) . Both the binding activity of Ott-4 and Ott-6 and transcriptional activation by the octamer motif are reduced upon differentiation of F9 stem cells (Scholer et al., 1989b) . Therefore, differentiation caused by ElA might be a reason for the reduced octamer activity described above.
To test if ElA affects proteins interacting with the octamer motif, a reporter gene containing an octamer next to the 8-globin TATA box (Schiiler et al., 1990b) was cotransfected with increasing amounts of the pElA vector into F9 cells. The CAT activity remained constant, and thus the activity of the Ott factors is not influenced by ElA when the octamer is close to the TATA box (data not shown). into F9 cells. Aliquots of the transfected F9 cells were used for (A) the CAT assay (30%) and(B) the EMSA. The extracts were incubated for 1 hr in the CAT assay; to demonstrate the gradual decrease of the CAT activity, a 3 hr exposure of the experiment is shown. In the binding reaction 0.5 tug of poly(dl-dC) was incubated with the octamer probe 1W. In (C), cotransfection was as in (A) except that pH6APr-1-neo-12s and pH6APr-lneo-13S were used as expression vectors and pHBAPr-1-neo as carrier DNA. Ten percent of the cell extract was incubated for 1 hr. In (D) the reporter plasmid and in (E) the expression vectors are schematically outlined.
examined in the EMSA, decreasing amounts of transfected pCMV-Oct4 resulted in decreasing amounts of Ott-4 ( Figure 26 ). The highest CAT signal was obtained with an intermediate amount of lane 5) . When the same experiment was performed in cells without ElA, transcription was not stimulated with any amount of Ott-4 (Scholer et al., 1990b; see below) . This indicates that not only expression of both Ott-4 and ElA is needed for transcriptional activation, but in addition a certain ratio of Ott-4 and ElA (or a factor induced by El A) appears to be required. Because a low amount of Ott-4 is sufficient for transcriptional activation, modification as a major cause of repression can be ruled out by this experiment.
In p6WtkCAT the distance between the 6W enhancer and the TATA box is about 150 bp (Schbler et al., 1990b) . To test if Ott-4 can stimulate transcription from a more distant position, 6W was cloned downstream of the CAT gene ( Figure 2D ). When this plasmid was cotransfected with pCMV-Oct4 in 293 cells, transcription was activated up to 15-fold as compared with Ott-4 expressed in the antisense orientation ( Figure 2C ). Although the stimulation is lower than from the 5'position (7.5fold), this result demonstrates that Ott-4 can also activate transcription from a downstream position in the presence of ElA.
A Certain Ratio of Ott-4 and ElA Is Necessary for Enhancer Stimulation in HeLa Cells Expression of ElA in F9 cells and of Ott-4 in 293 cells indicates that a certain ratio of both factors is needed for optimal transcriptional activation. To test this in detail, various ratios of Ott-4 and ElA were cotransfected with a constant amount of p6WtkCAT into HeLa cells (Figure 3 ). In this experiment four different amounts of the El A vector were combined with five different amounts of pCMV-OcM, resulting in 20 different combinations.
Aliquots of the transfected HeLa cells were used for the CAT assay left) and for the EMSA to determine the amount of expressed Ott-4 (right).
When high amounts of the ElA vector were used (10 ug in subset A) any amount of pCMVOct4 increased transcription above the level that was obtained in the absence of Ott-4, with an optimum at 0.8 ug of pCMVOct4 DNA. Thesameoptimum wasobtained with25 pgof ElAvector (subset B), but the activity had decreased. With even less ElA vector DNA (0.8 ug in subset C) the overall activity had not only decreased again, but also the optimum had changed, now at 0.2 ug of pCMV-Oct4 DNA. With the lowest amount of ElA vector DNA (0.2 ug in subset D) no transcriptional activation could be achieved with any amount of pCMV-OcM. Both the optimum and the overall activity changed in a way indicating that Ott-4 and ElA have to be present in a certain ratio and concentration to mediate transcriptional activation. The EIA vector to pCMV-Oct4 ratio has to be higher than 3 to obtain optimal transcriptional activation at a given ElA concentration, therefore no activation is found in Figure 30 .
In some cases expression of the CAT gene is higher without than with Ott-4 ( Figure 3D ). This basal signal is probably due to El A, because ElA can stimulate pGWtk-CAT in HeLa cells ( Figure 3G ). Therefore, expresston of Ott-4 inhibits a p6WtkCAT activity caused by El A. ElA stimulates the expression of p6WtkCAT about 4-fold more than that of p6FdtkCAT ( Figure 3G ), suggesting that ElA also activates Ott-1. A decrease in expression due to Ott-4 is also seen with 293 cells (Figure 2 ; compare lanes 1 and 7). as a reporter. Aliquots of the transfected 293 cells were used for (A) the CAT assay (30%) and (B) the EMSA. The extracts were incubated for 1 hr in the CAT assay. In the EMSA 0.5 ug of poly (dl-dC) was coincubated with the IW probe. In (C) two different reporter plasmids (with the 6W enhancer either 5'or 3'of the CAT gene) were cotransfected with 0.25 ng of Ott-4 expression vector and carrier DNA. Thirty percent of the extract was incubated for 2 hr. In (D) the reporter plasmids and in (E) the expression vector used are schematically
outlined. The open ellipse represents the POU-specific domain and the shaded ellipse the POU homeodomain.
Enhancer Stimulation
Depends on Expression of the 13s El A Gene Product In F9 cells the 289R protein dramatically repressed GW-mediated activation of transcription, whereas this was only reduced slightly by the 243R protein ( Figure 1C ). To determine which of the two is responsible for activation, increasing amounts of the same expression vectors were cotransfected with a constant amount of the Ott-4 expression vector and the reporter plasmid ( Figure 4 ). With two different 13s expression vectors the 6W enhancer could be activated, whereas with the 12s expression vector only a slight stimulation could be determined (activation by pHPAPr-neo-13s not shown). In parallel an ElA mutant in the 13Sspecific domain was tested that has been shown to be less efficient in transactivation experiments (Lillie et al., 1986; Lillie and Green, 1989; Liu and Green, 1990 ). This mutant is about 3-to 4-fold less efficient in the transactivation assay than the unmutated ElA 289R protein.
Enhancer Activation
Is Higher by Ott-4 Than by Ott-2 To test if Ott-2 could replace Ott-4, varying amounts of Ott-2 and Ott-4 were expressed in 293 cells and compared ( Figure 5 ). The results of the CAT assay demonstrate that transcriptional activation by Ott-2 occurs but is lower than activation by Ott-4 ( Figure 5A , upper left). The relative amounts of expressed Ott proteins were examined by analyzing aliquots of the transfected cells in the EMSA (Figure 58) .
Two other expression vectors were tested in the trans- activation experiment in 293 cells ( Figure 5A , upper left). The first vector harbored Ott-4 in the antisense orientation, the other a cDNA that was derived from a naturally occurring Ott-2 mRNA (A. Stoykova et al., submitted). pCMV-MiniOctP contained almost only the Ott-2 POU domain ( Figure 5D ). In both cases transcriptional activation by the 6W enhancer could not be achieved. Therefore, the Ott-2 POU domain is not sufficient for stimulation of the 6W enhancer. Several other controls were included in this experiment. First, the effect of each vector on the enhancer with the octamer mutant was tested in 293 and HeLa cells. None of them influenced the residual tkCAT expression, indicating that transcriptional activation is specific for the octamer ( Figure 5A , right).
To study transactivation by Ott-2 and Ott-4 in HeLa cells, an intermediate DNA amount (5 to 10 ug) had been used for transfection of the expression vectors (Mtillerlmmergliick et al., 1988; Rosner et al., 1990; Schbler et al., 1990b) . With these DNA amounts activation is low or absent in 293 cells (Figure 2A) . Therefore, varying amounts of the same expression vectors were also transfected into HeLa cells together with p6WtkCAT ( Figure 5A, shown because the length of electrophoresis had been prolonged. In (E) the reporter plasmid and in (F) the expression vectors used are schematically outlined. Open ellipses represent the POU-specific domain and shaded ellipses the POU homeodomain.
The numbering of the Ott-4 sequences is according to Schdler et al. (199Oa) . In (G) is shown the evaluation of an experiment in which the effect of ElA on either wild-type (p6WtkCAT) or a mutated octamer motif (p6FdtkCAT) had been tested (for the mutated octamer see Figure 5C ).
Ott (p6WtkCAT) or a mutated octamer motif (p6FdtkCAT).
Aliquots of the transfected cells were used for (A) the CAT assay (30%; 30 min) and (B) the EMSA (6 pg of whole-cell extract). In (A) an evaluation of the CAT assay is shown; in (8) binding of the Ott-2 and Mini-Oct2 is shown in the presence of 0.5 jrg of poly(dl-dC).
The different amounts of the expression vectors used for transfection are indicated in the figure. In (C)the reporter plasmids and in (D) the expression vectors are schematically outlined. Open ellipses represent the POU-specific domain and shaded ellipses the POU homeodomain. 293/HeLa lower left). However, at best a slight increase could be al., 1989b), demonstrating that nuclear transport is not evaluated with the Ott-2 and Ott-4 expression vectors, affected ( Figure 66 ). Therefore, the transactivating doand thus activation of the 6W enhancer depends on ElA main of Ott-4 and the conserved region 3 in ElA are regene product(s). quired for enhancer stimulation.
Enhancer Stimulation by Ott-4 Can Be Achieved by Different Transactivation Regions Both Ott-4 and ElA contain transactivating domains; in the case of Ott-4 the domain is "acidic" (Okamoto et al., 1990; Lillie and Green; 1989; Martin et al., 1990) . The ElA activating region appears to interact with a cellular target not required for the activation by transcription factors with acidic activating regions (Martin et al., 1990) . Therefore, we examined if ElA is sufficient for transcriptional activation if Ott-4 lacks the acidic domain. Two 5' deletion mutants of Ott-4 were expressed in 293 cells and tested for activation of p6WtkCAT (Figure 6 ). The deletions either included the whole N-terminal region up to the POU domain or about half of it ( Figure 6D ). Binding of both proteins was unaffected, but transcriptional activation was impaired ( Figures 6A and 6B ). To ascertain that the deletion mutants are transported to the nucleus, nuclear extracts were prepared and analyzed in the EMSA (Schreiber et Stimulation of 6W is higher by Ott-4 than by Ott-2 (Figure 5) . In contrast to the whole Ott-2 protein, its POU domain could not activate the 6W enhancer. Therefore, as outlined for Ott-4, stimulation by Ott-2 depends on its transactivation domain(s). Two regions in Ott-2 contribute to transactivation; the stronger one is rich in glutamine residues (Gerster et al., 1990; Mijller-lmmergltick et al., 1990; Tanaka and Herr, 1990) . Such a glutamine-rich region is absent in Ott-4. To distinguish the contribution of the POU domain from that of the transactivation domain(s), the glutamine-rich region of Ott-2 was cloned in the N-terminal region of both Ott-4 deletion mutants (Figure 6D ). With this region transactivation could be restored to levels between that of Ott-2 and Ott-4 ( Figure 6A ). Because the activity of the Ott-2-Ott-4 hybrid is above that of Ott-2, we conclude that both POU domains can interact with ElA (or a factor induced by it) and that this interaction is stronger for the Ott-4 POU domain. For a given POU domain, the strength of enhancer stimulation then depends on the transactivation domain linked to it. Aliquots of the transfected 293 cells were used in parallel for (A) the CAT assayand(B)the EMSA(3ugof nuclearextract incubated with the IW probe and 0.5 pg Of poly(dl-dC).
In the CAT assay 30% of the cells transfected were incubated for 30 min. In (A) an evaluation of the CAT assay is given. In (6) only the complexes of Ott-4 and its mutants are presented.
Therefore, the free probe and the complexes common in each lane are not shown (e.g., the Ott-1 complex).
In (C) the reporter plasmid and in (D) the expression vectors used are schematically outlined. Open ellipses represent the POU-specific domain and shaded ellipses the POU homeodomain.
The numbering of the Ott-4 sequences is according to Schdler et al. (1990a) .
Ott-4/B-Related Protein-Protein Complexes Are Formed in 293 Cells To achieve transcriptional activation from a distance, Ott-4 is thought to interact with other factor(s), such as EIA or a factor induced by ElA. To test this notion, 293 extracts with Ott-4 were examined for protein-protein complexes. Two bands correlate with the presence and the intensities of Ott-4 and Ott-5 in 293 cells, thus named tentatively Ott-4/5-related complexes ( Figure 7A ; compare lanes 1 and 2 with lanes 3 and 4).
Ott-4 cannot stimulate transcription without the transactivation domain even when ElA is present (Figure 6 ). To determine if the truncated Ott-4 proteins still form Ott-4-related complexes, aliquots of the extracts with these proteins were examined in the EMSA (data not shown; for a different purpose the 20ct-4 deletion mutant and its related complex are shown in Figures 8A and 8B ). Again complexes with lower mobility are formed with a pattern similar to that of Ott-4 and its truncated forms, indicating that factor binding to Ott-4 is not affected when the N-terminal region of Ott-4 is missing.
The Ott-415related complexes are labile because they are destroyed by competitor DNA, bromophenol blue, or xylene xyanol ( Figure 7A ; compare lanes 3 and 4 with lane 5). When low amounts of Ott-4 were expressed in 293 cells, no Ott-4/5-related complexes could be detected in the EMSA (data not shown). Due to their lability, any attempt to immunoprecipitate the Ott-4/5-related complexes according to Harlow et al. (1986) were not successful. The translation products were separated with a 15% polyacrylamide gel (Laemmli, 1970 Figure 78 ). When Ott-4 and El A sense RNAwere translated in vitro, two additional complexes with lower mobility were obtained (lane 2), whereas Ott-4 RNA translated alone or together with 13s ElA antisense RNA gave only Ott-4 and Ott-5 complexes (lanes 1 and 3) . No ElAcontaining complex is detectable with 13s ElA sense or antisense RNA translated alone (lanes 4 and 5) or with 12s ElA RNA (data not shown). Therefore, the complexes are specific for the 289R protein. The presence of the two El A-Ott-4 complexes reduces the Ott-4 signal to about 50% of that obtained without ElA (compare lane 2 with lanes 1 and 3).
The two ElA-Ott4 complexes might be due to two translation products, although 13s and 12s ElA translated in the presence of [%]methionine in each case only gave one prominent product ( Figure 7C ). Both El A-Ott-4 complexes might also be due to binding of one and two ElA proteins to one Ott-4 or vice versa. Similar to the complexes found with 293 cell extracts, these complexes are labile because they are destroyed by either low amounts of competitor DNA, bromophenol blue, or xylene xyanol.
The Conserved Domain 3 of the 289R ElA Protein Is Required for Binding to Ott-4 In the presence of Ott-4, 13s ElA expression vectors strongly activate the 6W enhancer (Figure 4) . In contrast, a vector expressing the smaller splicing product only slightly activated this enhancer. To correlate the functional assay with the binding assay, a deletion mutant of Ott-4 was coexpressed with different ElA proteins in HeLacells. The extracts of these cells were subsequently used to determine the efficiency of El A-Ott-4 complex formation (Figure 8A) . The Ott-4 deletion mutant was useful because it facilitated the separation of the ElA-Ott-4 complex from the strong nonspecific complex with lower mobility. This strong band is not due to Ott-1 binding, because both complexes are separated after a prolonged gel electrophoresis ( Figure 8D ). With the HeLa extract containing the 289R protein, a strong 20ct-4-related complex was obtained (lane 1). The 13s 1098 mutation also gave a protein that formed a complex with Ott-4, although this complex was less prominent (lane 2). When an extract containing the 243R protein was examined, a very faint band with a slightly higher mobility could be detected after a prolonged exposure (lane 3; longer exposure not shown).
Coexpression of 135 ElA and Ott-4 RNA in a reticulocyte lysate shows that both proteins can bind to each other ( Figure 7B ). The presence of ElA in the Ott-4-related complex derived from HeLa cells was determined by antibodies against ElA (Harlow et al., 1985) . Monoclonal antibodies were incubated with extracts containing the 20ct-4-related complex. However, although this complex was abolished by different antibodies, an additional shift in the EMSA could not be obtained. This was most probably due to precipitation of the complex (data not shown). To avoid precipitation, the Fab fragments of several antibodies were purified ( Figure 8C ). These were then added to extracts containing the 20ct-4 protein and either the 289R EIA protein or its mutated counterpart (Figure 88 ). With poly(dl-dC) only the Ott-4 deletion mutant is detected (20ct-4; Figure 88 , lane 1). Without competitor DNA and with spermidine a 20ct-4-related complex was found with both ElA proteins (Figure 88, lanes 2 and 3) . After binding of the M73 Fab fragments these complexes were retarded in the EMSA ( Figure 8B, lanes 4 and 5) . Therefore, we conclude that Ott-4 and ElA can bind to each other.
Discussion
A comparison of the expression of Ott-4 (Rosner et al., 1990; Schdler et al., 1990b) and the permissivityfor growth of certain viruses during early mouse embryogenesis and in EC cells (reviewed in Kelly and Condamine, 1982) reveals a striking complementary pattern. Unlike Ott-4, genes of SV40 and polyomavirus are not expressed in pluripotent cells, whereas expression is reversed in differentiated cells. The fact that enhancers of both viruses are considered to be repressed by an ElA-like factor (Imperiale et al., 1984; Gorman et al., 1985; Hen et al., 1986) prompted us to investigate if the same factor might stimulate transcriptional activation by Ott-4. As the initial step to elucidate such a relationship, we studied the influence of adenovirus ElA on the activity of Ott-4.Asshown in this report, El AandOct-4canstimulate transcription synergistically from adistance. Both proteins have to be present in a certain ratio; higher expression of either results in a loss of transcriptional activation. Since ElA and Ott-4 can bind to each other in vitro, ElA is an intriguing candidate for a bridging factor of Ott-4 in vivo. Enhancer stimulation by Ott-4 can be achieved either by its own transactivation domain or by one of Ott-2. Therefore, the previously described transactivation domain of ElA is not sufficient. Instead, this domain appears to be important for ElA to interact with Ott-4. ElA also stimulates O&P-mediated gene activation, which is significantly lower than that of Ott-4. Similar to Ott-4, Ott-2 depends on a functional transactivation domain.
A Possible Mechanism of ElA-Mediated Activation In HeLa cells a weak promoter consisting only of an octamer next to the TATA box (pDPCAT) was readily induced by Ott-4 and Ott-2, whereas in p6WtkCAT the more distally located 6W enhancer could not be activated (SchBler et al., 1990b) . Our results indicate that Ott-4 and Ott-2 are sufficient to activate via a proximal octamer motif but need additional factor(s) for distance-independent activation. The simplest model is that Ott-4 needs a bridging factor to be connected with the basal initiation complex and that ElA is the most likely candidate (Figure 9 , middle). Such a bridging factor present in pluripotent but not in differentiated cells can explain why expression of Ott-4 in HeLa Ott-4 result in squelching of the BRF, while high amounts of ElA result in a mode of repression we term surface saturation. Due to surface saturation the BRF interaction sites of Ott-4 and the basal initiation complex contain bound BRFs, thus preventing both sites from being brought together. In pluripotent cells a stem cell-specific BRF is postulated. Since ElA can substitute for this factor, one candidate for the BRF in pluripotent cells is the ElA-like factor.
cells is not sufficient to activate via a distant octamer. Supposing thatthesimilarityof ElAand the El A-like factor can be extended to their role as bridging factors, the El Alike factor might be a bridging factor specific for embryonic stem cells.
To study the activity of the octamer in early embryogenesis, fertilized oocytes had been microinjected with pGWtkLacZ containing the same promoter as pGWtkCAT, cultivated to the blastocyst stage and subsequently analyzed for LacZ expression (Schaler et al., 1989b) . Although the Ott-4 gene is expressed throughout the blastocyst (Rosner et al., 1990; Schiiler et al., 1990b) , only cells of the ICM were positive for LacZ expression, indicating that this promoter is not active in trophectodermal cells (Schbler et al., 1989b) . One possible reason for this is that the El A-like activity needed for 6W stimulation is missing in these cells. In agreement with this notion, expression of SV40 and polyomavirus is readily detectable in the trophectoderm and not in the ICM (reviewed in Kelly and Condamine, 1982 ) and the El A-like factor appears to be down-regulated during the differentiation of EC stem cells (La Thangue and Rigby, 1987 , and references therein).
The dependence of activation on the Ott-4/ElA ratio probably reflects two different effects: ElA as a bridging factor would have to bind to two different proteins, whereas Ott-4 had to interact with only one protein. When Ott-4 is overexpressed, Ott-4-bridging factor complexes would be prevented from binding DNA by an excess of Ott-4 bound to the octamer motif (Figure 9, top) . In this case repression is acombination of squelching and competition (Levine and Manley, 1989; Ptashne and Gann, 1990 ). An excess of ElA might saturate the interaction sites of Ott-4 and the basal initiation complex bound to the promoter, thus preventing transcriptional activation (Figure 9 , bottom).
Repression by surface saturation postulates an interaction of ElA with TATA box factors, which is independent of other promoter elements. In agreement with this notion, the tk promoter is stimulated by ElA ( Figure 3G and data not shown). A stimulation of TATA-binding factor(s) by ElA has been analyzed in detail for other transcription units, such as adenovirus El 6, j3-globin, hsp70, histone Hl, and c-fos, where the TATA element is essential for transactivation by ElA (Nevins, 1981; Green et al., 1983; Wu et al., 1987; Simon et al., 1988) . These genes have the TATAA sequence in common and are stimulated lo-to 30-fold. In contrast, the early SV40 promoter contains a TATA element that is not induced by ElA (TATTTAT; Simon et al., 1988) . It is possible that distinct TATA factors interact with thedifferent TATAsequencesandonlytheTATAA-binding factor is stimulated by ElA.
The tk TATA element is stimulated 3-to 4-fold. Although this TATA is similar to the @globin element (CATATAA), it contains an additional T (CATATTAA) and thus does not exactly fit with the consensus sequence TATAA. Two different factors with distinct binding specificities or a single TATA factor recognizing both TATA elements in a different manner might explain why the tk TATA is less activated than the 6-globin TATA.
Surface saturation can also explain why the activity of the octamer is repressed in F9 cells by ElA, although binding of none of the Ott factors is affected. If F9 cells contain a certain amount of bridging factor optimal for transactivation, any additional bridging factor would saturate the binding sites of the participating proteins with the same consequences as outlined above (Figure 9, bottom) . Although the F9 cell experiments indicate a bridging factor required for distance-independent activation, they cannot exclude the possibility that the bridging activity of the bridging factor is affected by El A, e.g., by modification, or that its expression is down-regulated by El A. Although Ott-4 and ElA clearly bind to each other in vitro, this does not exclude the possibility that ElA induces a cellular factor that itself serves as a bridging factor in vivo. However, we think that this is unlikely, because transcriptional activation depends on a defined ratio of Ott-4 and ElA and not on the total amount of El A. For the same reasons we think that posttranslational modifications are not the major cause of transcriptional activation by Ott-4.
The lability of the El A-Oct4complex to competitor DNA was somewhat surprising but could be due to at least two reasons. The most plausible one is that ElA is directly competed by DNA, because the 289R ElA protein nonspecifically binds to DNA, including poly(dl-dC) (Chatterjee et al., 1988) . Alternatively, a cellular factor might be necessary to stabilize the El A-Ott-4 complex. If this factor binds nonspecifically to DNA it could be competed out, thus weakening the El A-Ott-4 complex. This kind of stabilization has been proposed for the interaction of VP18 with Ott-1 . A cellular factor, distinct from Ott-1 , binds to VP1 6 in the absence of target DNA and is necessary for VP16-mediated complex assembly with Ott-1 (Kristie and Sharp, 1990; Xiao and Capone, 1990) .
A slightly different model has been proposed for ElAmediated activation of ATF-2 (Liu and Green, 1990) . In that case, ElA is attached on one surface to the DNA-binding protein ATF-2 and on another to an additional component necessary for transcriptional activation. This third factor is supposed to support ATF-2 with an (acidic) activating region. In contrast to ATF-2, Ott-4 has a transactivation domain (Okamoto et al., 1990) , and therefore ElA alone is sufficient for transcriptional activation. Transcriptional activation is lost when the transactivation domain of Ott-4 is deleted, indicating that this domain cannot be substituted by a third component or by ElA (Martin et al., 1990) . Thus the mechanism of transcriptional activation by ElA appears to be different for ATF-2 and Ott-4.
The 243R El A protein at best binds weakly to Ott-4. This protein lacks the conserved domain 3, which is present in the larger 289R ElA protein. A mutation in this domain that has been reported to affect promoter binding strongly (Lillie and Green, 1989 ) also reduces binding of ElA to Ott-4 approximately 2-to 3-fold. This mutant protein is also less active in enhancer stimulation than wild-type ElA. The ElA mutation 1098 changes amino acid 180 from a glycine to an aspartic acid. Lillie and Green showed that an ElA segment containing the conserved domain 3 (121 to 223) fused to the DNA-binding domain of the yeast transcriptional activator GAL4 could activate transcription of the E4 promoter even in the absence of GAL4 binding sites. However, transactivation was abolished with the mutant ElA protein. In contrast, when GAL4 sites were introduced 240 bp upstream of the El B TATA, both the wildtype and the mutant El A proteins activated transcription to a similar extent. Therefore, the mutation can be overcome when linked to a DNA-binding domain. It is possible that ElA binds via the conserved domain 3 to Ott-4 and that binding is slightly affected by the 1098 mutation. If this kind of interaction occurs, another surface of ElA might be responsible for linking the El A-Ott4 complex to the basal initiation complex.
The conserved domain 3 of ElA has two interesting features: it is acidic and it binds zinc (Gulp et al., 1988) . POU domains contain four basic clusters, one in each center of the POU-specific subdomains and one at both ends of the POU homeodomain (SchBler, 1991) . These basic clusters are regions to which the 289R protein ElA might bind. Alternatively, the possible zinc finger might interact with Ott-4. A mutational analysis of Ott-4 will define which region is responsible for the El A-Ott4 interaction.
Repression in Lymphoid Cells and Activation in Fibroblast Cells: ElA and the Other Ott Factors ElA activates stimulation of transcription by Ott-2 and even Ott-1, although the effect of both these proteins is much lower than that of Ott-4. Again, stimulation depends on transactivation domain(s), indicating that the mechanism of transcriptional activation is similar for these Ott factors. The difference with respect to activation by each Ott factor is most probably due to the interacting surfaces. An example for different interacting surfaces has been reported for Ott-1 and Ott-2. The herpes simplex protein VP16 specifically activates Ott-I (Gerster and' Roeder, 1988) because it binds to the homeodomain of Ott-1 and not to that of Ott-2 (Stern et al., 1989) . In addition, the transactivation domain of Ott-4 might be stronger than for both other Ott factors. This is possible, because transcriptional activation via an octamer next to a TATA box is stronger for Ott-4 than for Ott-2 (SchBler et al., 1990b; Suzuki et al., 1990) .
In certain cases expression of Ott-4 can slightly decrease transcriptional activation to levels below that when only Ott-1 is present, probably due to squelching of ElA by Ott-4 (Figures 3 and 5) . As outlined above, ElA might not serve as a bridging factor for Ott-1 when it is titrated out by Ott-4 (Figure 9 , top). This kind of repression has to be kept in mind when the effect of Ott-4 (or of any other Ott factor) on a possible target gene is tested. As a consequence the Ott factor tested can behave as a repressor, although under physiological conditions it activates a gene. A titration experiment might help to investigate the activating and repressing potential of a certain transcription factor (see Figure 2) . Ott-4 might also exert both activities in vivo. This is not unlikely, because depending on its context the octamer motif confers both repression and activation in F9 cells (Lenardo et al., 1989; Schijler et al., 1990b) . Actually, most of the eukaryotic transcriptional repressors also function as activators (Levine and Manley, 1989) .
Activation of the octamer motif by ElA has also been shown by Chellappan and Nevins (1990) . They suggested that this is due to increased Ott-1 binding; however, their results cannot exclude the possibility that Ott-1 activates transcription also by additional protein-protein interactions. In their experiments CV-1 cells had been infected with Ad5 for 18 hr and therefore most of the cells might have contained ElA. In our experiments no changes in Ott-1 binding were detectable. This might be due to a limited number of transfected cells too low to give a signal above that of Ott-1 from untransfected cells.
An interaction of ElA with Ott-2 and Ott-1 would also explain why the IgH enhancer is repressed by ElA in lymphoid cells but is stimulated in fibroblasts (Hen et al., 1985; Borrelli et al., 1986) . Surface saturation could account for repression of the IgH enhancer by ElA in lymphoid cells (Hen et al., 1985) . If an Ott-2 bridging factor in lymphoid cells were replaceable by ElA, too high amounts of ElA would lead to saturation of the binding sites on Ott-2 and on the basal initiation complex (Figure  9 , bottom). In fibroblasts ElA might serve as a bridging factor, resulting in activation of Ott-I ( Figure 3G ; Chellappan and Nevins, 1990 ) and, as a consequence, in activation of the IgH enhancer (Borrelli et al., 1986) .
The ElA-like Factor as a Potential Bridging Factor in EC Cells ElA can confer on primary cells the capacity for unlimited proliferation (Houweling et al., 1980; Ruley, 1983) . ElA may be substituting for the cellular function of a growth regulator and so immortalize a cell. The genes conferring cell immortality are not known; therefore, it is of interest to consider gene regulation in stem cells that acquire a finite lifespan when they differentiate. It is characteristic of a number of stem cell types that expression of certain differentiation-specific functions commences with the loss of potential for unlimited growth. An example of this relationship between growth and expression of differentiation-specific functions is provided by EC cells. MHC class I antigens, which are repressed by ElA of Ad12 immortalized primary cells (Schrier et al., 1983) , are expressed only at a very low level in undifferentiated EC cells (Croce et al., 1981; Morello et al., 1982) . Thus, for the MHC class I antigens, ElA may reproduce a state in immortalized primary cells normally found in undifferentiated cells. Although it is not known whether the repression of MHC class I antigen genes in EC cells or in Ad12 immortalized cells involves enhancer elements present in the MHC class I antigen genes, a clear example of the dependence of enhancer function on the differentiation state is presented by polyomavirus. The enhancer element for the polyoma early promoter is inactive in undifferentiated EC cells but becomes transcriptionally active after the cells are induced to differentiate (reviewed in Kelly and Condamine, 1982) . Furthermore, rearrangements of the enhancer elements enable mutant polyomaviruses to grow in undifferentiated EC cells (reviewed in Sleigh, 1985) . One of these mutants contains a point mutation in the enhancer. This enhancer is not repressed by El A products (Hen et al., 1986) , whereas wild-type polyoma enhancer is (Borrelli et al., 1984) .
Taken together, our results suggest that EIA substitutes for the El A-like activity as a bridging factor between Ott-4 (or other transcription factors) and the basal initiation complex. Similar to the ElA product(s), the ElA-like activity might interact with other factors, resulting in activation or repression of certain genes in pluripotent cells. As a consequence, changes in the amount of only the El A-like activity could up-or down-regulate several genes simultaneously upon differentiation of the pluripotent progenitor cells. Because Ott-4 is the candidate for a factor interacting with the ElA-like activity, we now might have a tool to screen for the El A-like activity. These studies may help in understanding gene regulation during early embryogenesis and also may give an idea as to why pluripotent cells have the capacity for unlimited proliferation.
Experimental Procedures
Cell Lines and Transfection; Assay for Chloramphenicol Acetyltransferase HeLa, 293, and F9 stem cells were grown and transfected as described elsewhere (Schdler and Gruss, 1984; Schdler et al., 1989b) . Briefly, approximately 10" cells were plated onto 10 cm tissue culture dishes 3 hr before addition of the calcium phosphate precipitate and refed 30 min before addition of the precipitate.
The precipitate was left on the cells for 20 hr; thereafter the cells were refed and harvested after an additional 8 hr. Twenty percent of the harvested cells were used for the microextraction procedure, and the rest for the CAT assay, which was performed as outlined before (Schbler and Gruss, 1984; Schdler et al., 1990b) . The standard exposure time was 16 hr. The total amount of DNA in the transactivation experiment was 26 pg, of which 6 ng was from reporter plasmid. Except when outlined otherwise in the figure legends, Bluescript DNA (Stratagene) was used as carrier to achieve the total amount necessary for optimal transfection.
Recombinant Plasmids and Oligonucleotides The reporter plasmids (p6WtkCAT and p6FdtkCAT) and the expression vector pCMV-Oct4 have been described previously (Schdler et al., 1969b, 1 SSOb). p6WtkCAT was created by cloning the 6W enhancer in the Smal site of pBLCAT2 (Luckow and Schutz, 1967 Mini-Oct2 is a 323 amino acid protein containing the POU domain and 26 additional N-terminal and 44 C-terminal amino acids of Ott-2 and thus lacks most of the transactivation domain(s) (Gerster et al., 1990; Miiller-lmmergltick et al., 1990; Tanaka and Herr, 1990) . The vectors pCMV-lOct4, pCMV-POct4, and pCMV-160ct4 expressing truncated Ott-4 protein were created by cutting different Ott-4 cDNA clones with EcoRl (in 5' linker CCGGAATTCCGG) and Accl (in 3' untranslated region at bp 1018; Schdler et al., 199Oa) and by subsequent fill-in reaction and blunt-end ligation in pEVRF0 or pEVRF2, which had been restricted with Smal (Matthias et al., 1989) . The Ott-4 sequences expressed in these vectors are numbered according to Schdler et al. (1990a) : pCMVlOct4, bp 316 to 1018 (Accl) in pEVRF0; pCMV-16OcM; bp 215 to 1018 in pEVRF2; pCMV-20ct4; bp 208 to 1018 in pEVRF0. pCMV-Gln-lOct4
and pCMV-Gln-POct4 were created by inserting the 200 bp Hincll-Smal fragment containing the glutamine-rich sequence of hOct-2 (bp 348 to 547; numbering according to Clerc et al., 1988) into the unique BamHl site of the pEVRF vectors (Matthias et al., 1989) that had been blunt-ended with Klenow and dNTPs. ETA Expression Vectors pElA contains fragment 0 to 1771 bp of Ad5 cloned in the pBR322 derivate pML-2. pH8APr-1-neo-12s and pHf3APr-I-neo-13s are described in Weigel et al. (1990) ; pH6APr-1-neo is described in Gunning et al. (1988) . pH3G-13s and pH3G-13S/1098 were described in Lillie et al. (1986) . Plasmids for In Vitro Transcription The 135 ElA RNA was produced with PBS-EIA (Ad5 13s ElA cloned in PBS), 12s EIA RNA with pGEM-12s (12s EIA cloned in pGEM-1). Ott-4 RNA was produced with the Juhachi clone as described previously (Schdler et al., 199Oa) .
The 1 W oligonucleotide used in the EMSA has been described previously (Scholer et al., 1989a) . This probe contains the heavy chain gene enhancer octamer motif.
Microextraction
Procedure for the Preparation of Whole-Cell Extracts and the EMSA The microextraction procedure was performed as described previously (Schdler et al., 1990b) . A standard binding reaction contained 6 ng of protein extract, 1 pg of poly(dl-dC), and 10,000 cpm of 1 W probe; any deviation from these values is outlined in the figure legends. To obtain protein-protein complexes, the standard binding reaction as described in Schiiler et al. (1989a) was modified: approximately 10 pg of a freshly prepared whole-cell extract (prepared either directly after cell harvest or from frozen pellet) was preincubated for 30 min at 2.5% in a volume of 10 nl containing 20 mM HEPES (pH 7.6) at 25°C 20% glycerol, 40 mM KCI, and 9 mM spermidine.
Subsequently, 5 nl of radiolabeled 1 W probe (in 20% glycerol and 20 mM HEPES [pH 7.61 at 25%) was added to the mixture and further incubated for 30 min at 25°C. Neither poly(dl-dC) nor blue dye marker was used. In the antibody experiment the Fab fragments were added with the IW probe.
